ATE364390T1 - Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen - Google Patents

Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen

Info

Publication number
ATE364390T1
ATE364390T1 AT99902261T AT99902261T ATE364390T1 AT E364390 T1 ATE364390 T1 AT E364390T1 AT 99902261 T AT99902261 T AT 99902261T AT 99902261 T AT99902261 T AT 99902261T AT E364390 T1 ATE364390 T1 AT E364390T1
Authority
AT
Austria
Prior art keywords
vitamins
reducing
allium
homocystein
serum
Prior art date
Application number
AT99902261T
Other languages
English (en)
Inventor
Harunobu Amagase
Original Assignee
Wakunaga Of America Co Ltd
Harunobu Amagase
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Of America Co Ltd, Harunobu Amagase filed Critical Wakunaga Of America Co Ltd
Application granted granted Critical
Publication of ATE364390T1 publication Critical patent/ATE364390T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99902261T 1998-08-13 1999-01-13 Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen ATE364390T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/133,267 US6129918A (en) 1998-08-13 1998-08-13 Method and pharmaceutical composition for reducing serum homocysteine concentration

Publications (1)

Publication Number Publication Date
ATE364390T1 true ATE364390T1 (de) 2007-07-15

Family

ID=22457780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902261T ATE364390T1 (de) 1998-08-13 1999-01-13 Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen

Country Status (10)

Country Link
US (1) US6129918A (de)
EP (1) EP1105145B1 (de)
AT (1) ATE364390T1 (de)
AU (1) AU775544B2 (de)
CA (1) CA2340227C (de)
DE (1) DE69936307T2 (de)
ES (1) ES2289806T3 (de)
IL (2) IL141303A0 (de)
NZ (1) NZ509770A (de)
WO (1) WO2000009141A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906740D0 (en) * 1999-03-23 1999-05-19 Kilgowan Limited Oral combinations of hydroxocobalamin and folic acid
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030077264A1 (en) * 2001-09-20 2003-04-24 Goodrich Laura L. Antimicrobial blood treatment using allicin and related compounds
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
DE102005001479A1 (de) * 2005-01-12 2006-07-20 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
DE102005009379A1 (de) 2005-03-01 2006-09-07 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
US7201929B1 (en) * 2005-12-30 2007-04-10 Alan James Group, Llc. Aspirin formulation for cardiovascular health
US8586537B2 (en) * 2006-05-25 2013-11-19 Rick Tope Method for treating minor aphthous ulcers
US20080045448A1 (en) * 2006-08-18 2008-02-21 Alan Robert Vinitsky Reversing autonomic nervous system dysfunction by potentiating methylation
NZ585280A (en) * 2007-10-16 2011-05-27 Exichol Sa Composition for regulating lipid metabolism
US20150290323A1 (en) * 2014-04-11 2015-10-15 Sam Houston State University Dialkyl trisulfides and formulations of dialkyl trisulfides for use as a cyanide antidote
CN103976331A (zh) * 2014-05-28 2014-08-13 彭常安 一种荞头茎叶调味粉的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6067409A (ja) * 1983-09-22 1985-04-17 Suntory Ltd 頭髪用化粧料
US4737364A (en) * 1986-02-06 1988-04-12 Kalogris Theodore P Nutritional dry food concentrate
US5231114A (en) * 1990-06-22 1993-07-27 Wakunaga Seiyaku Kabushiki Kaisha Polysulfides compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient
AU1265295A (en) * 1993-12-10 1995-06-27 Sami A. Hashim Reducing likelihood of vascular disorders in susceptible patients
JP2608252B2 (ja) * 1994-09-16 1997-05-07 名古屋製酪株式会社 ニンニクの加工処理方法およびアホエン含有油脂の製造方法
CN1123113A (zh) * 1994-11-18 1996-05-29 郭湘泗 用于特效减肥的超浓缩营养素

Also Published As

Publication number Publication date
AU775544B2 (en) 2004-08-05
CA2340227A1 (en) 2000-02-24
DE69936307T2 (de) 2008-02-14
EP1105145A4 (de) 2004-04-07
DE69936307D1 (de) 2007-07-26
EP1105145A1 (de) 2001-06-13
CA2340227C (en) 2011-01-11
IL141303A (en) 2006-08-20
ES2289806T3 (es) 2008-02-01
IL141303A0 (en) 2002-03-10
NZ509770A (en) 2003-08-29
WO2000009141A1 (en) 2000-02-24
US6129918A (en) 2000-10-10
EP1105145B1 (de) 2007-06-13
AU2228399A (en) 2000-03-06

Similar Documents

Publication Publication Date Title
ATE364390T1 (de) Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen
EA200100872A1 (ru) Композиция валдекоксиба
UY28041A1 (es) Metodos de dosis bajas para el tratamiento de trastornos en los cuales la actividad del tnfa es perjudicial.
MXPA04004376A (es) Complementos nutricionales, y metodos para la prevencion, reduccion y tratamiento de lesion por radiacion.
CU20000176A7 (es) Composiciones de celecoxib
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
DE50214447D1 (de) Ingwer-extraktzubereitung
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
PT1414473E (pt) Composicoes de administracao oral para o tratamento de disturbios do couro cabeludo
NO975858D0 (no) Anvendelse av et ekstrakt av Cimicifuga racemosa
WO2004010946A3 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
ATE290388T1 (de) Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c
NZ326345A (en) Composition containing diosgenin
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
SE8403659D0 (sv) Synergistic pharmaceutical composition
DE60236443D1 (de) Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie
IL175358A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
ATE369135T1 (de) Behandlung von depression und zusammensetzungen dazu
DE60100431D1 (de) Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln
EA199700025A1 (ru) Применение олигосахарида и аспирина для приготовления медикаментов, предназначенных для лечения тромбоэмболических заболеваний, фармацевтическая композиция, способ лечения
UA39141C2 (uk) Засіб "кратал" для лікування захворювань серцево- судинної системи
IL175357A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
Montgomery et al. Fluoxetine or placebo in suicidal behaviour
BR0215498A (pt) Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties